SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gutiérrez, M A
Right arrow Articles by Jacobelli, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutiérrez, M A
Right arrow Articles by Jacobelli, S
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus

M A Gutiérrez

M E Garcia

Departments of Clinical Immunology and Rheumatology, Santiago, Chile

J A Rodriguez

Departments of Endocrinology, Pontificia Universidad Católica de Chile, Santiago, Chile

S Rivero

Departments of Clinical Immunology and Rheumatology, Santiago, Chile

S Jacobelli

The objective was to study the response of cortisol and of prolactin (PRL) to specific stimuli in systemic lupus erythematosus (SLE). We measured the response of cortisol to insulin-induced hypoglycemia and of PRL to thyrotropin releasing hormone (TRH) in seven patients with active untreated SLE and in ten paired control subjects. All were women with regular menstrual cycles. With the exception of two patients, they had never received corticosteroids before the study.

The basal serum levels of cortisol (12.5 2.4 µg/dl) and PRL (10.7 1.0 ng/ml) in the SLE group were not significantly different from those of the control group (12.3 1.1 mg/dl and 13.7 2.4 ng =ml, respectively). The cortisol response after hypoglycemia was significantly lower in SLE patients compared to the control group at 45 min (P = 0.01), at 60 min (P = 0.009), and at 90 min (P = 0.001). The integrated cortisol response to hypoglycemia expressed as area under the response curve (AUC) did not differ significantly in either group (1447 187 vs 1828 84, P = 0.06). Although the peak of PRL after TRH did not differ significantly in both groups (68.0 7.4 ng =ml in SLE vs 66.3 77 ng/ml in controls) and the AUC of PRL response after TRH was comparable in both groups (4672 537 vs 4128 541, P = 0.32), the interval-specific ‘delta’ response was significantly higher in SLE than the control group at 0–60 min (P = 0.02) and 0–90 min (P = 0.01) after TRH injection.

These findings suggest that active SLE is associated with some degree of dysfunction of the hypothalamic-pituitary-glucocorticoid axis and PRL secretion.

Key Words: lupus • cortisol • prolactin • hypothalamic-pituitary axis

Lupus, Vol. 7, No. 6, 404-408 (1998)
DOI: 10.1191/096120398678920343


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
Y. Kuramochi, T. Kato, M. Sudou, H. Sugano, H. Takagi, and T. Morita
Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy
Lupus, June 1, 2007; 16(6): 447 - 449.
[Abstract] [PDF]


Home page
J. Clin. Pathol.Home page
C C Mok and C S Lau
Pathogenesis of systemic lupus erythematosus
J. Clin. Pathol., July 1, 2003; 56(7): 481 - 490.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
S E Walker and L.-y. Yu-Lee
Overview: prolactin and autoimmunity
Lupus, October 1, 2001; 10(10): 659 - 659.
[PDF]


Home page
LupusHome page
A M Jacobi, W Rohde, M Ventz, G Riemekasten, G-R Burmester, and F Hiepe
Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity
Lupus, August 1, 2001; 10(8): 554 - 561.
[Abstract] [PDF]


Home page
LupusHome page
S E Walker, D Miller, D L Hill, and G R Komatireddy
Prolactin, a pituitary hormone that modifies immune responses: Proceedings of the Mini-symposium on Prolactin and SLE, held at the 5th International Conference on Systemic Lupus Erythematosus, Cancun, Mexico
Lupus, July 1, 1998; 7(6): 371 - 375.
[PDF]



Advertisement